Kevin P. Kerns

Array ( [id] => 7774761 [patent_doc_number] => 08119771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Products for altering IL-33 activity and methods thereof' [patent_app_type] => utility [patent_app_number] => 12/451053 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 35 [patent_no_of_words] => 15511 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119771.pdf [firstpage_image] =>[orig_patent_app_number] => 12451053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4584959 [patent_doc_number] => 07851596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides' [patent_app_type] => utility [patent_app_number] => 12/111079 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 83 [patent_no_of_words] => 69647 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851596.pdf [firstpage_image] =>[orig_patent_app_number] => 12111079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452158 [patent_doc_number] => 20090068195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING AND MONITORING TREATMENT OF IL-13-ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/107456 [patent_app_country] => US [patent_app_date] => 2008-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 72644 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068195.pdf [firstpage_image] =>[orig_patent_app_number] => 12107456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271562 [patent_doc_number] => 20090075338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'DIMERIC FUSION PROTEINS AND MATERIALS AND METHODS FOR PRODUCING THEM' [patent_app_type] => utility [patent_app_number] => 12/106616 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13649 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075338.pdf [firstpage_image] =>[orig_patent_app_number] => 12106616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6411663 [patent_doc_number] => 20100166694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'DIAGNOSTIC MARKERS OF WOUND INFECTION' [patent_app_type] => utility [patent_app_number] => 12/450377 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10246 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166694.pdf [firstpage_image] =>[orig_patent_app_number] => 12450377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823024 [patent_doc_number] => 20080227709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'GENE EXPRESSION IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM CHILDREN WITH DIABETES' [patent_app_type] => utility [patent_app_number] => 12/046874 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13337 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227709.pdf [firstpage_image] =>[orig_patent_app_number] => 12046874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13344 [patent_doc_number] => 07803557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Methods for identification of eicosapentaenoic acid analogs using anti-inflammatory receptors' [patent_app_type] => utility [patent_app_number] => 12/045427 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 6577 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803557.pdf [firstpage_image] =>[orig_patent_app_number] => 12045427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621592 [patent_doc_number] => 08354506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Antibodies for the selective determination of procalcitonin 1-116' [patent_app_type] => utility [patent_app_number] => 12/529089 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8794 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12529089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314293 [patent_doc_number] => 20100111966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'ENGINEERED ANTI-IL-23P19 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/527456 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25118 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111966.pdf [firstpage_image] =>[orig_patent_app_number] => 12527456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361576 [patent_doc_number] => 20090036370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Leukocyte Adhesion Inhibitor-1 (LAI-1)' [patent_app_type] => utility [patent_app_number] => 12/029050 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 39965 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036370.pdf [firstpage_image] =>[orig_patent_app_number] => 12029050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256073 [patent_doc_number] => 07575741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Methods of treating cutaneous ulcers and grafts using IL-23' [patent_app_type] => utility [patent_app_number] => 12/026437 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13523 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575741.pdf [firstpage_image] =>[orig_patent_app_number] => 12026437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204338 [patent_doc_number] => 07629147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'PEGylated soluble GP130-dimers useful as a medicament' [patent_app_type] => utility [patent_app_number] => 12/026476 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8196 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629147.pdf [firstpage_image] =>[orig_patent_app_number] => 12026476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852014 [patent_doc_number] => 20080317756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Antibodies to Chemokine Alpha-5' [patent_app_type] => utility [patent_app_number] => 12/010210 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25041 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317756.pdf [firstpage_image] =>[orig_patent_app_number] => 12010210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675237 [patent_doc_number] => 08383350 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-02-26 [patent_title] => 'Assay for detection of IL-10 antibodies' [patent_app_type] => utility [patent_app_number] => 11/960517 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12267 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11960517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141239 [patent_doc_number] => 07691366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Chimeric CMP-Ang1 molecule' [patent_app_type] => utility [patent_app_number] => 11/956291 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13696 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691366.pdf [firstpage_image] =>[orig_patent_app_number] => 11956291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786123 [patent_doc_number] => 20080139452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Secreted proteins and polynucleotides encoding them' [patent_app_type] => utility [patent_app_number] => 12/000468 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 137134 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139452.pdf [firstpage_image] =>[orig_patent_app_number] => 12000468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430739 [patent_doc_number] => 20100143340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/518405 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24465 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143340.pdf [firstpage_image] =>[orig_patent_app_number] => 12518405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785504 [patent_doc_number] => 20080138833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR ASSESSING IL-12 OR THE NEUTRALIZATION OF IL-12 IN A SAMPLE' [patent_app_type] => utility [patent_app_number] => 11/949958 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11958 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138833.pdf [firstpage_image] =>[orig_patent_app_number] => 11949958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824922 [patent_doc_number] => 20080124325 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'PREVENTIVE OR THERAPEUTIC AGENT FOR PSORIASIS COMPRISING IL-6 ANTAGONIST AS ACTIVE INGREDIENT' [patent_app_type] => utility [patent_app_number] => 11/947267 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10469 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124325.pdf [firstpage_image] =>[orig_patent_app_number] => 11947267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601254 [patent_doc_number] => 20100098709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor' [patent_app_type] => utility [patent_app_number] => 12/516935 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30562 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098709.pdf [firstpage_image] =>[orig_patent_app_number] => 12516935 [rel_patent_id] =>[rel_patent_doc_number] =>)